Is Mestinon an Immunosuppressant?

Mestinon (pyridostigmine) has been used to treat postural tachycardia syndrome (POTS) and may improve symptoms such as a fast heart rate (tachycardia) and symptom burden (Raj et al., 2005). However, research that investigated the addition of Mestinon to standard beta-blocker treatment (propranolol or bisoprolol) found no additional advantage with the addition of Mestinon and suggested beta-blocker therapy alone to be the preferred option (Moon et al., 2018) Continue reading

Mestinon is a prescription medicine that can help relieve symptoms of myasthenia gravis (MG) such muscle weakness, double vision, blurred vision, drooping eyelids, loss of facial expressions, and difficulties with talking, chewing food, swallowing and breathing. There is no cure for MG, but treatments can help with symptoms. Continue reading

Mestinon is a common treatment for myasthenia gravis but 25% of all patients who take it discontinue it because of side effects, and many discontinue it because it does not make any difference to their symptoms. Because it is short-acting, it could theoretically be stopped without tapering it, but you should always talk to your doctor about stopping it before you do so. Continue reading